Please login to the form below

Not currently logged in

Longitude Prize awards grants for antibiotic test development

Five UK teams among the winners seeking to tackle antimicrobial resistance

Pharma struggling to make multichannel data work

New survey finds firms are hampered by lack of access to real-time data

AZ's Tagrisso beats chemotherapy in lung cancer trial

Phase III data shows greater progression-free survival in mutation-positive NSCLC patients

Pfizer gets record £84m fine for hiking price of epilepsy drug

US firm plans to appeal after CMA finds it raised NHS fee by 2,600% in 2012

Keytruda closes in on Opdivo's lead in Hodgkin lymphoma

Merck and Co - US headquartersKEYNOTE-087 trial shows an overall response rate of 69%

New Jardiance label could boost sales by $1.7bn, says analyst

boehringer-jardiance-diabetesDiabetes treatment can reduce the risk of cardiovascular death in type 2 patients

Pfizer's SMO inhibitor boosts survival in blood cancer trial

Glasdegib first to show benefit in patients with AML or MDS

Novartis plans filing for lead CAR-T therapy early next year

Novartis buildingShows complete remission for 82 percent of paediatric and young adult B-cell ALL patients

AZ signs $1bn deal with Bicycle Therapeutics

AstraZeneca AZEyes broad range of applications for the firm’s peptide technology

Assisting adherence

How one app aims to support patients

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Understanding the chronic disease patient journey in emerging markets
Infographic: Keeping tracking on track
Our best practice approach to tracking studies....
What does the Five Year Forward View mean for pharma?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess how the Five Year Forward View (5YFV) is changing the NHS and how pharma can get involved in redesigning NHS services....